|Name||PRICE||MARKET CAPITALIZATION||PRICE TO EARNINGS RATIO||DIVIDEND YIELD||SYMBOL||EXCHANGE||PRICE PERCENT DIFFERENCE||YEAR TO DATE PRICE PERCENT DIFFERENCE||5 YEAR CHART||1 YEAR CHART|
Spark Therapeutics Inc [ONCE]
$108.84 0.78 (0.72%)
Market Cap 4.17 Billion
Spark Therapeutics Inc is a United States based company operating in the field of gene therapy. It is focused on debilitating genetic diseases by developing one-time, life-altering treatments. The company's product candidates are in the field of retina-directed gene therapies, liver-directed gene therapies, and central nervous system therapies. The entity's key product, LUXTURNA, is for the treatment of patients with viable retinal cells and confirmed biallelic RPE65 mutation-associated retinal dystrophy. It generates revenue primarily from the license and collaborative agreements.
EPS -1.43 P/E Ratio 0.00
Previous Earnings Tue, Nov 6, 2018
Pay Date --
This list of trending stocks may change throughout the trading day.